[1] |
WU Wenjun, WEI Jingjing, LI Xue, REN Hongjie, YU Rui, PENG Guangcao, ZHU Mingjun.
Regularity of Prescriptions for Coronary Heart Disease with Hypertension Based on Latent Structure and Association Rules
[J]. Chinese General Practice, 2025, 28(30): 3787-3795.
|
[2] |
BAI Jiaxin, CHEN Yu, ZHOU Yiheng, LIU Lidi, YANG Rong, YAO Yi, YUAN Bo, ZHANG Yonggang, LEI Yi, ZENG Rui, JIA Yu, LIAO Xiaoyang.
Assessment and Treatment of Early-onset Hypertension: Position Statement of the British and Irish Hypertension Association and Its Implications for Clinical Management of Early-onset Hypertension in China
[J]. Chinese General Practice, 2025, 28(30): 3741-3746.
|
[3] |
QIN Bangguo, SUN Jin, LI Man, QIU Jiaojiao, CHENG Bokai, ZHU Ping, WANG Shuxia.
Relationship between Non-high-density Lipoprotein Cholesterol to High-density Lipoprotein Cholesterol Ratio and Left Ventricular Hypertrophy in a Community-based Hypertensive Population
[J]. Chinese General Practice, 2025, 28(30): 3753-3760.
|
[4] |
ZHANG Peng, LIU Lidi, ZHANG Ying, YANG Ziyu, LIU Changming, TANG Yijun, LIAO Xiaoyang, JIA Yu.
Interpretation and Clinical Implications of the 2024 Italian Guidelines for the Management of Adult Individuals with Overweight and Obesity and Metabolic Comorbidities That are Resistant to Behavioral Treatment
[J]. Chinese General Practice, 2025, 28(30): 3747-3752.
|
[5] |
CHEN Junyu, HAN Guangli, LI Chunhong, CHEN Yidi, YANG Nana, LUO Xiaoxi.
Classification Study of Self-management Types among Pregnant Women in Rural Areas Based on Cluster Analysis
[J]. Chinese General Practice, 2025, 28(26): 3289-3293.
|
[6] |
HAN Xiao, LI Qiyu, GE Pu, FAN Siyuan, LIU Diyue, WU Yibo, ZHANG Qingshuang.
The Impact of Behavioral Lifestyle on Quality of Life in Hypertensive Patients
[J]. Chinese General Practice, 2025, 28(26): 3248-3258.
|
[7] |
XIANG Xinyue, ZHANG Bingqing, OUYANG Yuqin, TANG Wenjuan, FENG Wenhuan.
Impact of Short-term Medical Weight Loss on Atherosclerotic Cardiovascular Disease Risk in Patients with Obesity
[J]. Chinese General Practice, 2025, 28(26): 3229-3239.
|
[8] |
YU Zizi, LIU Duli, LI Ximin, RUAN Chunyi, YIN Xiangyang, CAI Le.
Analysis of the Prevalence and Self-management of Hypertension and Its Influencing Factors in Rural
[J]. Chinese General Practice, 2025, 28(25): 3137-3143.
|
[9] |
TANG Shangfeng, HUANG Yangzhen, PAN Yangyang, ZHENG Yanxi, XIONG Zhongbao, ZHANG Kangkang, SONG Jia, WEI Yilin, WANG Chunying, DONG Heng, CHEN Manwei, QING Hua.
Specification for the Integration of Healthcare and Prevention Services in Hypertension at the Primary Level
[J]. Chinese General Practice, 2025, 28(25): 3089-3095.
|
[10] |
JI Bing, JIANG Dudu, CHEN Chen, ZHENG Yanling, SHI Jianwei, FANG Lizheng, DU Xueping.
Constructing a Comprehensive Community Clinical Pathway for Herpes Zoster under Graded Treatment Framework
[J]. Chinese General Practice, 2025, 28(25): 3110-3118.
|
[11] |
YAN Fanghong, PENG Guotian, ZHANG Guoli, SUN Ruiyi, MA Yuxia, HAN Lin.
Matching Analysis of the Content of Chronic Disease Management for the Elderly in Medical Union: Based on the Perspective of "Guidance-Practice-Need"
[J]. Chinese General Practice, 2025, 28(25): 3119-3126.
|
[12] |
WEI Yunhong, YANG Li, WANG Yulu, YE Qiufang, DAI Anni, HE Yan.
Study on Cardiopulmonary Function During Different Exercise Stages in Patients with Obesity-related Hypertension
[J]. Chinese General Practice, 2025, 28(24): 2972-2978.
|
[13] |
HE Jinyu, ZHULIDUZI Jiesisibieke, ZHANG Ning, LIU Min, LIANG Wannian.
Research on Blood Pressure Control and Its Determinants Among Hypertensive Patients Under Standardized Management in China: Status, Challenges, and Future Directions
[J]. Chinese General Practice, 2025, 28(24): 2968-2971.
|
[14] |
WANG Peng, QIU Lixia, XU Shanshan, ZHANG Yang, ZHANG Jing, DU Xiaofei.
Advances in the Co-management of Metabolism Dysfunction-associated Fatty Liver Disease and Type 2 Diabetes Mellitus
[J]. Chinese General Practice, 2025, 28(23): 2846-2851.
|
[15] |
BAI Xue, CHEN Qianqian, LI Jie.
Innovative Practices in Chronic Disease Management: a New Model for Generalist-Specialist Combination Management of Diabetes and Metabolic Dysfunction-associated Fatty Liver Disease
[J]. Chinese General Practice, 2025, 28(23): 2841-2845.
|